Clinical Trial Update: Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating two oral doses of PG-760564 in rheumatoid arthritis patients receiving methotrexate. The study is completed and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• PG-760564

Snippet

Sponsor: Procter and Gamble | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2011-09-08